Thrive Capital Management (Pennsylvania) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.8M |
| 2 |
iShares Core Moderate Allocation ETF
AOM
|
+$1.15M |
| 3 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$1M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
+$928K |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$896K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short Maturity Bond ETF
NEAR
|
+$796K |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$489K |
| 3 |
West Pharmaceutical
WST
|
+$345K |
| 4 |
Janus Henderson Short Duration Income ETF
VNLA
|
+$300K |
| 5 |
NextEra Energy
NEE
|
+$254K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.58% |
| 2 | Healthcare | 6.37% |
| 3 | Consumer Staples | 3.73% |
| 4 | Communication Services | 2.76% |
| 5 | Financials | 2.75% |
Similar funds
Thrive Capital Management (Pennsylvania)'s Q3 2021 Portfolio in Review
As of Q3 2021, Thrive Capital Management (Pennsylvania) held 111 positions worth $135M, up 5.3% from $129M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Thrive Capital Management (Pennsylvania) deployed $8.62M of net new capital in Q3 2021, opening 2 new positions and adding to 45 existing holdings. Its largest new stake was Invesco S&P 500 Low Volatility ETF: 3,924 shares worth $239K.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 8.7% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $796K trimmed.
- Thrive Capital Management (Pennsylvania)'s largest Q3 2021 buy was Invesco S&P 500 Low Volatility ETF: 3,924 shares worth $239K.
- Thrive Capital Management (Pennsylvania) added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q3 2021, an estimated $1.8M increase.
- Thrive Capital Management (Pennsylvania)'s biggest Q3 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $796K.
- Thrive Capital Management (Pennsylvania) fully exited West Pharmaceutical in Q3 2021, selling an estimated $345K.
- Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 40% of its $135M portfolio in Q3 2021.
- Thrive Capital Management (Pennsylvania) opened 2 new positions and closed 4 in Q3 2021.
- Thrive Capital Management (Pennsylvania)'s portfolio value rose 5.3% quarter-over-quarter to $135M.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q3 2021, filed 12 Nov 2021.